Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, PO Box 80082, 3508 TB Utrecht, the Netherlands.
Nanoscale. 2020 May 14;12(18):10347-10360. doi: 10.1039/d0nr03147j.
One of the challenges for the clinical translation of RNA interference (RNAi)-based therapies concerns the deposition of therapeutically effective doses of the nucleic acids, like siRNA, at a local tissue level without severe off-target effects. To address this issue, hydrogels can be used as matrices for the local and sustained release of the siRNA cargo. In this study, the formation of polyplexes based on siRNA and poly(2-dimethylaminoethyl methacrylate) (PDMAEMA)-based polymers was investigated, followed by their loading in a thermosensitive hydrogel to promote local siRNA release. A multifunctional NPD triblock copolymer consisting of a thermosensitive poly(N-isopropylacrylamide) (PNIPAM, N), a hydrophilic poly(ethylene glycol) (PEG, P), and a cationic PDMAEMA (D) block was used to study the binding properties with siRNA taking the non-thermosensitive PD polymer as control. For both polymers, small polyplexes with sizes ranging from 10-20 nm were formed in aqueous solution (HBS buffer, 20 mM HEPES, 150 mM NaCl, pH 7.4) when prepared at a N/P charge ratio of 5 or higher. Formulating the siRNA into NPD or PD polyplexes before loading into the thermosensitive PNIPAM-PEG-PNIPAM hydrogel resulted in a more controlled and sustained release compared to free siRNA release from the hydrogel. The polyplexes were released for 128 hours in HBS, when changing the release medium twice a day, while free siRNA was completely released within 50 hours with already 40% being released after changing the release medium just once. The release of the polyplexes was dependent on the dissolution rate of the hydrogel matrix. Moreover, intact polyplexes were released from the hydrogels with a similar size as before loading, suggesting that the hydrogel material did not compromise the polyplex stability. Finally, it was shown that the released polyplexes were still biologically active and transfected FaDu cells, which was observed by siRNA-induced luciferase silencing in vitro. This study shows the development of an injectable thermosensitive hydrogel to promote local and sustained release of siRNA, which can potentially be used to deliver siRNA for various applications, such as the treatment of tumors.
基于 RNA 干扰 (RNAi) 的治疗在临床转化上面临的挑战之一是,如何将治疗有效剂量的核酸(如 siRNA)递送到局部组织水平,同时避免严重的脱靶效应。为了解决这个问题,可以使用水凝胶作为 siRNA 货物的局部和持续释放的基质。在这项研究中,研究了基于 siRNA 和基于聚(2-二甲氨基乙基甲基丙烯酸酯)(PDMAEMA)的聚合物的聚集体的形成,然后将其装载到温敏水凝胶中以促进局部 siRNA 释放。使用由热敏性聚(N-异丙基丙烯酰胺)(PNIPAM,N)、亲水性聚乙二醇(PEG,P)和阳离子 PDMAEMA(D)块组成的多功能 NPD 三嵌段共聚物来研究与 siRNA 的结合特性,并将非热敏性 PD 聚合物作为对照。对于两种聚合物,当在 N/P 电荷比为 5 或更高时,在 HBS 缓冲液(20 mM HEPES、150 mM NaCl、pH 7.4)中制备时,形成了尺寸在 10-20nm 之间的小聚集体。将 siRNA 制成 NPD 或 PD 聚集体,然后装载到温敏 PNIPAM-PEG-PNIPAM 水凝胶中,与水凝胶中游离 siRNA 的释放相比,可实现更受控和更持续的释放。在 HBS 中,当每天更换释放介质两次时,聚集体可释放 128 小时,而当仅更换释放介质一次时,游离 siRNA 则在 50 小时内完全释放,并且已经有 40%被释放。聚集体的释放取决于水凝胶基质的溶解速率。此外,从水凝胶中以类似的装载前大小释放出完整的聚集体,这表明水凝胶材料没有破坏聚集体的稳定性。最后,结果表明,释放的聚集体仍然具有生物活性,并转染 FaDu 细胞,这可以通过体外 siRNA 诱导的荧光素酶沉默来观察到。这项研究展示了一种可注射温敏水凝胶的开发,以促进 siRNA 的局部和持续释放,该水凝胶可潜在地用于递送 siRNA 用于各种应用,例如肿瘤的治疗。